Monday, 6 April 2020

Covid-19: 1.5mn doses of remdesivir ready for compassionate use, clinical trials

Gilead said it is providing the existing supply at no cost, to treat patients with the most severe symptoms of COVID-19.

Categories:

0 comments:

Post a Comment